
Carrier screening halves adverse outcomes in potentially low-risk egg donation treatments
The demand for treatments requiring oocyte donation has increased significantly due to delayed motherhood. According to data from the European Society of Human Reproduction and Embryology (ESHRE), Spain performs the highest number of such treatments in Europe.